Document Detail


New concepts in post-infarction ventricular remodeling.
MedLine Citation:
PMID:  14564229     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
An understanding of the process of left ventricular (LV) remodeling has led to greater knowledge of the pathophysiology of heart failure syndrome. This article examines the relationship between LV remodeling and clinical outcomes of heart failure syndrome from several different perspectives. The studies cited suggest that the post-myocardial infarction process is related to and associated with long-term progression of LV dysfunction, heart failure symptoms, and mortality. It is also demonstrated that drug therapies that slow or reverse the remodeling process appear to have favorable natural history effects in the short term as well as during long-term therapy.
Authors:
James E Udelson; Richard D Patten; Marvin A Konstam
Related Documents :
19525659 - Prognostic significance of diastolic dysfunction by tissue doppler imaging in patients ...
8279379 - Systolic time intervals after phenylephrine administration for early stratification of ...
10080429 - Association of left ventricular systolic performance and cavity size with angiotensin-c...
20132499 - Transthoracic sensor for noninvasive assessment of left ventricular contractility: vali...
15975359 - Transmural differences in myocardial function and metabolism during direct left ventric...
16352289 - Assessment of myocardial viability in ischemic cardiomyopathy.
25378469 - Idiopathic accelerated idioventricular rhythm or ventricular tachycardia originating fr...
22353149 - Measurement of the fetal isovolumetric contraction time in the fetus with a left ventri...
24051679 - Prognostic impact of anaemia on patients with st-elevation myocardial infarction treate...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Reviews in cardiovascular medicine     Volume:  4 Suppl 3     ISSN:  1530-6550     ISO Abbreviation:  Rev Cardiovasc Med     Publication Date:  2003  
Date Detail:
Created Date:  2003-10-17     Completed Date:  2003-12-09     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  100960007     Medline TA:  Rev Cardiovasc Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  S3-12     Citation Subset:  IM    
Affiliation:
Division of Cardiology, Tufts-New England Medical Center, Tufts University School of Medicine, Boston, Massachusetts, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adrenergic beta-Antagonists / therapeutic use
Angiotensin-Converting Enzyme Inhibitors / therapeutic use
Animals
Heart Failure / drug therapy,  physiopathology*
Humans
Myocardial Infarction / drug therapy,  physiopathology*
Renin-Angiotensin System / physiology
Sympathetic Nervous System / physiology
Ventricular Dysfunction, Left / physiopathology*
Ventricular Remodeling* / drug effects
Chemical
Reg. No./Substance:
0/Adrenergic beta-Antagonists; 0/Angiotensin-Converting Enzyme Inhibitors

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Evaluation of chest pain and heart failure in the emergency department: impact of multimarker strate...
Next Document:  Reappraisal of beta-blocker therapy in the acute and chronic post-myocardial infarction period.